Everolimus

Biological Activity for Everolimus

Technical Data for Everolimus

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility for Everolimus

References for Everolimus

References are publications that support the biological activity of the product.

• Lane et al. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin.Cancer Res., 2009;15:1612 PMID: 19223496
• Sedrani et al. Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant Proc., 1998;30:2192 PMID: 9723437
• Galluzzi et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat.Rev.Drug.Discov., 2017; PMID: 28529316